Snowball Research
Research hub for stocks under $5B
⌘K
Subscribe Sign in
paid-only post activistcompany

CLS Therapeutics Advocates for Management Overhaul at Xenetic Biosciences (XBIO) Following Stockholder Opposition to Executive Compensation

This post is for paying subscribers only

Subscribe to continue reading


More like this

Starboard Highlights Salesforce's (CRM)Operational Gains and Future Potential

Trium Capital Rejects Acelyrin (SLRN)-Alumis Merger, Urges Liquidation Instead

Galloway Opposes WW International, Inc (WW) Rumored Bankruptcy, Urges Debt Restructuring

Outerbridge Capital reaches agreement with Barnes & Noble Education (BNED)

Value Base Ltd Opposes Poison Pill, Citing Shareholder Harm at Perion Network Ltd (PERI)

Engine Capital Nominates Directors to Push for Change at Lyft (LYFT)